Cargando…

Controversies in the management of hepatocellular carcinoma

The management of hepatocellular carcinoma (HCC) has evolved considerably over the last decade. Surveillance of cirrhotic patients and refinements to imaging techniques have enabled a relevant proportion of patients to be diagnosed at an early stage, when effective therapies are feasible. Resection,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Forner, Alejandro, Da Fonseca, Leonardo G, Díaz-González, Álvaro, Sanduzzi-Zamparelli, Marco, Reig, María, Bruix, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001551/ https://www.ncbi.nlm.nih.gov/pubmed/32039350 http://dx.doi.org/10.1016/j.jhepr.2019.02.003

Ejemplares similares

Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity
por: da Fonseca, Leonardo G., et al.
Publicado: (2021)

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
por: Corominas, Josep, et al.
Publicado: (2021)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019)

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success
por: Da Fonseca, Leonardo G., et al.
Publicado: (2018)

The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments
por: Reig, Maria, et al.
Publicado: (2017)

Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs
por: Díaz‐González, Álvaro, et al.
Publicado: (2021)

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients—A Multiparametric Prediction
por: Muñoz-Martínez, Sergio, et al.
Publicado: (2023)

Portal Hypertension may Influence the Registration of Hypointensity of Small Hepatocellular Carcinoma in the Hepatobiliary Phase in Gadoxetic Acid MR
por: Caparroz, Carla, et al.
Publicado: (2022)

The Evolving Concept of the Multidisciplinary Approach in the Diagnosis and Management of Interstitial Lung Diseases
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2023)

Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
por: Sapena, Víctor, et al.
Publicado: (2022)

Management of hepatocellular carcinoma: An update
por: Bruix, Jordi, et al.
Publicado: (2011)

The Controversial Role of Polyploidy in Hepatocellular Carcinoma
por: Wang, Nan, et al.
Publicado: (2021)

Nasopharyngeal and Oropharyngeal Swabs, And/Or Serology for SARS COVID-19: What Are We Looking For?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Correlation between clinical-functional parameters and number of lobes involved in non-cystic fibrosis bronchiectasis
por: Giacon, Valeria, et al.
Publicado: (2021)

Controversies and evidence of hepatic resection for hepatocellular carcinoma()
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

Controversies in the Management of Endometrial Carcinoma
por: Zhang, Ying, et al.
Publicado: (2010)

Resection vs. transplantation for hepatocellular carcinoma: a never ending challenge
por: Ferrer-Fàbrega, Joana, et al.
Publicado: (2023)

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
por: Greten, Tim F, et al.
Publicado: (2010)

Controversies in the Management of Endometrial Carcinoma: An Update
por: Mehasseb, Mohamed K., et al.
Publicado: (2012)

Association between COVID-19 and Sick Leave for Healthcare Workers in a Large Academic Hospital in Southern Italy: An Observational Study
por: Palladino, Raffaele, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current Trends and Controversies
por: Schaub, Stephanie K., et al.
Publicado: (2018)

Alpha-1-Antitrypsin Deficiency and Bronchiectasis: A Concomitance or a Real Association?
por: Sanduzzi, Alessandro, et al.
Publicado: (2020)

Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
por: Kim, Soo Ki, et al.
Publicado: (2022)

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma
por: Rimassa, Lorenza, et al.
Publicado: (2017)

Controversies in imaging of hepatocellular carcinoma: multidetector CT (MDCT)
por: Silverman, Paul M, et al.
Publicado: (2005)

Description of a new rare alpha-1 antitrypsin mutation in Naples (Italy): PI*M S-Napoli
por: Mosella, Marco, et al.
Publicado: (2018)

Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
por: Couñago, Felipe, et al.
Publicado: (2019)

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
por: Deng, Zhu-Jian, et al.
Publicado: (2022)

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association
por: Allaire, Manon, et al.
Publicado: (2022)

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma
por: Tutusaus, Anna, et al.
Publicado: (2018)

Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
por: Cucarull, Blanca, et al.
Publicado: (2020)

Controversies in the Management of Endometrial Cancer
por: Masciullo, V., et al.
Publicado: (2010)

May Polyphenols Have a Role Against Coronavirus Infection? An Overview of in vitro Evidence
por: Annunziata, Giuseppe, et al.
Publicado: (2020)

Fine-Needle Aspiration Biopsy of Hepatocellular Carcinoma and Related Hepatocellular Nodular Lesions in Cirrhosis: Controversies, Challenges, and Expectations
por: Wee, Aileen
Publicado: (2011)

A Phase II Study on the Effect of Taurisolo(®) Administered via AEROsol in Hospitalized Patients with Mild to Moderate COVID-19 Pneumonia: The TAEROVID-19 Study
por: Sanduzzi Zamparelli, Stefano, et al.
Publicado: (2022)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
por: Gonzalez-Sanchez, Ester, et al.
Publicado: (2021)

miR-200c-3p, miR-222-5p, and miR-512-3p Constitute a Biomarker Signature of Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: de la Cruz-Ojeda, Patricia, et al.
Publicado: (2022)

Adrenal myelolipoma: Controversies in its management
por: Shenoy, Vasanth G., et al.
Publicado: (2015)

The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
por: Sanduzzi Zamparelli, Marco, et al.
Publicado: (2016)

Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline
por: Guo, Le-Hang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_srnfke29j49c5l7ah6iumtd531